SpineSmith, a Celling Biosciences company, announces that the United States Patent and Trademark Office has issued US Patent 8,273,127, covering the VisuALIF®, the first lumbar interbody device featuring a revolutionary open-face design.
In October 2010 the VisuALIF received FDA clearance per K102090 for commercial sale in the United States. The company has performed over 400 procedures utilizing the technology since its launch. The system is currently being utilized across the US with an anticipated CE marking for 2013. The VisuALIF family of products will include a lateral design, cervical design and unique plating designs for all approaches.
"The VisuALIF device is a comprehensive system designed for physicians to take advantage of maximum graft placement to optimize the fusion environment. We believe the unique design allows surgeons to dedicate the appropriate attention to all three key elements of the fusion procedure: cell biology, optimal substrates and the medical device," said Kevin Dunworth, founder of SpineSmith.
The proprietary technology is designed to give surgeons the option for in-situ graft delivery and provide the ability to choose the appropriate plate system depending on different anatomical challenges. The Challenging Access Plate is a unique plate that provides ease of use when approaching the challenges at the L5-S1 juncture.